Skip to main content
Back to News
ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A...
Funding
1 min read
SG

ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A...

The AMW Read

This is an incremental update regarding a new player in the AI-driven drug discovery space; it does not meet the $500M threshold for cross.§D.
NoveltySignificance
Healthcare & Bio · Player Map

ChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating AI-driven drug discovery. This move positions Singapore as a key hub for deep tech and biomedical innovation. With a market projected to reach nearly $50B by 2034, AI's impact on pharmaceutical R&D is rapidly transforming the industry, compressing discovery timelines from months to weeks.

#AIDiscovery #DrugDevelopment #Singapore #LifeSciences #AIforScience

How This Connects

Based on Healthcare & Bio · Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 5d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 5d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 8mo agoChemLex has secured $45M and launched its self-driving lab in Singapore, dramatically accelerating A... · THIS ARTICLE

Related News

More news from ChemLex

Stay updated with the latest news and announcements from ChemLex.

View all ChemLex news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard